KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Intangibles (2016 - 2026)

AbbVie has reported Intangibles over the past 14 years, most recently at $52.6 billion for Q4 2025.

  • Quarterly Intangibles fell 12.36% to $52.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $52.6 billion through Dec 2025, down 12.36% year-over-year, with the annual reading at $52.6 billion for FY2025, 12.36% down from the prior year.
  • Intangibles was $52.6 billion for Q4 2025 at AbbVie, up from $711.0 million in the prior quarter.
  • Over five years, Intangibles peaked at $81.3 billion in Q1 2021 and troughed at $711.0 million in Q3 2025.
  • The 5-year median for Intangibles is $63.9 billion (2023), against an average of $62.8 billion.
  • Year-over-year, Intangibles soared 346.59% in 2021 and then crashed 98.93% in 2025.
  • A 5-year view of Intangibles shows it stood at $76.0 billion in 2021, then dropped by 11.21% to $67.4 billion in 2022, then dropped by 17.54% to $55.6 billion in 2023, then grew by 8.02% to $60.1 billion in 2024, then fell by 12.36% to $52.6 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Intangibles are $52.6 billion (Q4 2025), $711.0 million (Q3 2025), and $57.0 billion (Q2 2025).